Home › Non-Muscle Invasive Bladder Cancer › New York › Syracuse
Non-Muscle Invasive Bladder Cancer clinical trials in Syracuse, NY
8 studies for Non-Muscle Invasive Bladder Cancer are looking for participants at sites in and around Syracuse (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
RecruitingPhase 2
- Associated Medical Professionals of NY, Syracuse
- State University of New York (SUNY) Upstate Medical University, Syracuse
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
RecruitingPhase 3
- Associated Medical Professionals, Syracuse
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
RecruitingPhase 1
- Upstate Specialty Services at Harrison Center, Syracuse
- SUNY Upstate Medical University, Syracuse
- SUNY Upstate Medical University-Community Campus, Syracuse
A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
RecruitingObservational study
- SUNY Upstate Med Univ, Syracuse
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
RecruitingPhase 2
- Associated Medical Professionals of NY, PLLC, Syracuse
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
RecruitingPhase 1/2
- Associated Medical Professionals of NY,, Syracuse
ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG
RecruitingPhase 1/2
- SUNY Upstate Medical University, Syracuse
Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients
RecruitingPhase 2
- Site 02-015 - Associated Medical Professionals of New York, Syracuse
Non-Muscle Invasive Bladder Cancer trials in other cities
- Columbus, OH10 studies
- Dallas, TX10 studies
- New York City, NY10 studies
- Myrtle Beach, SC9 studies
- Edison, NJ9 studies
- Baltimore, MD8 studies
- Nashville, TN8 studies
- Houston, TX7 studies
- Indianapolis, IN7 studies
- Birmingham, AL7 studies
- Philadelphia, PA7 studies
- Atlanta, GA7 studies
Other studies in Syracuse
- Non-Small Cell Lung Cancer15 studies
- Cancer (all types)9 studies
- Prostate Cancer9 studies
- Ovarian Cancer7 studies
- Endometrial Cancer7 studies
- Obesity6 studies
- Lung Cancer6 studies
- Colorectal Cancer5 studies
- Macular Degeneration5 studies
- Acute Myeloid Leukemia5 studies
- Type 2 Diabetes5 studies
- Lupus5 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.